Trial intelligence / Profile preview

Intensive Vasodilator Therapy in Essential Hypertension

NCT01180413Phase 4Completed

Sponsor
Aarhus University Hospital
Start
Dec 2010
Primary completion
Apr 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of amlodipine, ramipril, lercanidipine, losartan in essential hypertension, sponsored by Aarhus University Hospital. Started Dec 2010; status: completed.

02

Drugs

amlodipineramiprillercanidipinelosartan
03

Conditions

essential hypertension

Beyond the preview

Go deeper on NCT01180413.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01180413.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call